Over the holidays, Alex Lieberman had an idea: What if he could create Spotify “Wrapped” for his text messages? Without writing a single line of code, Lieberman, a co-founder of the media outlet ...

Anthropic’s agentic tool Claude Code has been an enormous hit with some software developers and hobbyists, and now the company is bringing that modality to more general office work with a new feature ...

OpenJDK project teams will focus work on features such as value types, code reflection, AOT compilation, and structured concurrency in the coming year. Oracle’s Java team in 2026 will work toward ...

A monthly overview of things you need to know as an architect or aspiring architect. Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with ...

When the creator of the world's most advanced coding agent speaks, Silicon Valley doesn't just listen — it takes notes. "If you're not reading the Claude Code best practices straight from its creator, ...

Hoyoverse just wrapped up the Genshin Impact version "Luna 4" (or 6.3, as some others would liek to call it) preview livestream, showing off all sorts of details about the upcoming patch. Most ...

WASHINGTON — President Donald Trump's campaign to remake landmarks of the nation's capital in his image expanded into the realm of golf this week with his administration's termination of leases on ...

Netflix gave Us an early Christmas present by releasing the first Peaky Blinders: The Immortal Man movie trailer. The minute-long clip, which dropped on Wednesday, December 24, opens with a graying ...

Sam Altman’s decision to declare a “code red” at OpenAI earlier this month may have caught the industry’s attention, but it wasn’t a first for the artificial intelligence company. The San ...

The items were taken in the late 19th century from what was then called the Dutch East Indies. Indonesia had been trying to get them back for decades. By Nina Siegal Reporting from Amsterdam The ...

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast ...